# Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma

> **NCT03702491** · PHASE2 · UNKNOWN · sponsor: **Eastern Hepatobiliary Surgery Hospital** · enrollment: 138 (estimated)

## Conditions studied

- Gallbladder Carcinoma

## Interventions

- **DRUG:** Apatinib
- **DRUG:** Tegafur

## Key facts

- **NCT ID:** NCT03702491
- **Lead sponsor:** Eastern Hepatobiliary Surgery Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-10
- **Primary completion:** 2020-08-10
- **Final completion:** 2020-08-10
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2018-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03702491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03702491, "Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03702491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*